• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Utility of gonadotropin-releasing hormone agonists for fertility preservation in women receiving chemotherapy: pros and cons.

作者信息

Dolmans Marie-Madeleine, Taylor Hugh S, Rodriguez-Wallberg Kenny A, Blumenfeld Zeev, Lambertini Matteo, von Wolff Michael, Donnez Jacques

机构信息

Pôle de Gynécologie, Institut de Recherche Expérimentale et Clinique (IREC), Université Catholique de Louvain, Brussels, Belgium; Gynecology Department, Cliniques Universitaires Saint Luc, Brussels, Belgium.

Department of Obstetrics, Gynecology and Reproductive Sciences, Yale School of Medicine, New Haven, Connecticut.

出版信息

Fertil Steril. 2020 Oct;114(4):725-738. doi: 10.1016/j.fertnstert.2020.08.011.

DOI:10.1016/j.fertnstert.2020.08.011
PMID:33040981
Abstract
摘要

相似文献

1
Utility of gonadotropin-releasing hormone agonists for fertility preservation in women receiving chemotherapy: pros and cons.促性腺激素释放激素激动剂在接受化疗的女性中用于生育力保存的效用：利弊
Fertil Steril. 2020 Oct;114(4):725-738. doi: 10.1016/j.fertnstert.2020.08.011.
2
Can ovarian suppression with gonadotropin-releasing hormone analogs (GnRHa) preserve fertility in cancer patients?使用促性腺激素释放激素类似物（GnRHa）进行卵巢抑制能否保留癌症患者的生育能力？
Ann Oncol. 2016 Feb;27(2):357. doi: 10.1093/annonc/mdv554. Epub 2015 Nov 25.
3
Gonadotropin-releasing hormone agonists for ovarian protection during cancer chemotherapy: systematic review and meta-analysis.促性腺激素释放激素激动剂在癌症化疗中对卵巢的保护作用：系统评价和荟萃分析。
Ultrasound Obstet Gynecol. 2018 Jan;51(1):77-86. doi: 10.1002/uog.18934. Epub 2017 Dec 1.
4
Preservation of gonadal function in women undergoing chemotherapy: a review of the potential role for gonadotropin-releasing hormone agonists.化疗女性性腺功能的保护：促性腺激素释放激素激动剂潜在作用的综述
Am J Obstet Gynecol. 2016 Oct;215(4):415-22. doi: 10.1016/j.ajog.2016.06.053. Epub 2016 Jul 13.
5
Gonadotropin-Releasing Hormone Agonists for Ovarian Function Preservation in Premenopausal Women Undergoing Chemotherapy for Early-Stage Breast Cancer: A Systematic Review and Meta-analysis.促性腺激素释放激素激动剂在早期乳腺癌化疗的绝经前妇女中保存卵巢功能的作用：系统评价和荟萃分析。
JAMA Oncol. 2016 Jan;2(1):65-73. doi: 10.1001/jamaoncol.2015.3251.
6
Protecting Ovaries During Chemotherapy Through Gonad Suppression: A Systematic Review and Meta-analysis.通过性腺抑制在化疗期间保护卵巢：一项系统评价和荟萃分析。
Obstet Gynecol. 2015 Jul;126(1):187-95. doi: 10.1097/AOG.0000000000000905.
7
Failure of Ovarian Suppression With Gonadotropin-Releasing Hormone Analogs to Preserve Fertility: An Assessment Based on the Quality of Evidence.促性腺激素释放激素类似物抑制卵巢功能以保护生育力失败：基于证据质量的评估
JAMA Oncol. 2016 Jan;2(1):74-5. doi: 10.1001/jamaoncol.2015.3252.
8
Ovarian suppression using luteinizing hormone-releasing hormone agonists during chemotherapy to preserve ovarian function and fertility of breast cancer patients: a meta-analysis of randomized studies.化疗中使用促黄体生成素释放激素激动剂抑制卵巢功能以保留乳腺癌患者的卵巢功能和生育能力：一项随机研究的荟萃分析。
Ann Oncol. 2015 Dec;26(12):2408-19. doi: 10.1093/annonc/mdv374. Epub 2015 Sep 7.
9
Gonadotrophin-releasing hormone agonists for fertility preservation: unraveling the enigma?促性腺激素释放激素激动剂在生育力保存中的应用：揭开谜团？
Hum Reprod. 2015 May;30(5):1089-101. doi: 10.1093/humrep/dev037. Epub 2015 Mar 21.
10
Utility of gonadotropin-releasing hormone agonists for fertility preservation in young breast cancer patients: the benefit remains uncertain.促性腺激素释放激素激动剂在年轻乳腺癌患者生育力保存中的应用：获益仍不确定。
Ann Oncol. 2013 Sep;24(9):2224-35. doi: 10.1093/annonc/mdt196. Epub 2013 May 24.

引用本文的文献

1
Luteinizing Hormone Preserves Oocyte-Granulosa Cell Communication in Growing Follicles Exposed to Chemotherapy with Alkylating Agents at the Primordial Stage in a Mouse Model.在小鼠模型中，促黄体生成素可维持原始阶段暴露于烷化剂化疗的生长卵泡中卵母细胞-颗粒细胞的通讯。
Reprod Sci. 2025 Aug 6. doi: 10.1007/s43032-025-01936-1.
2
BFGF mitigates CTX-induced ovarian cytotoxicity via SERPINE1/HIF-1 and Nrf-2/HO-1 signaling pathways.碱性成纤维细胞生长因子通过丝氨酸蛋白酶抑制剂E1/缺氧诱导因子-1和核因子E2相关因子2/血红素加氧酶-1信号通路减轻环磷酰胺诱导的卵巢细胞毒性。
J Ovarian Res. 2025 Jul 12;18(1):151. doi: 10.1186/s13048-025-01736-w.
3
Effects of Chemotherapy on Fertility and Fertility Preservation Strategies for the Women of Childbearing Potential Undergoing Chemotherapy: A Comprehensive Review.
化疗对生育力的影响及化疗期有生育潜力女性的生育力保护策略：综述
Indian J Surg Oncol. 2025 Apr;16(2):401-407. doi: 10.1007/s13193-024-02103-9. Epub 2024 Sep 26.
4
Ferrostatin-1 ameliorates Cis-dichlorodiammineplatinum(II)-induced ovarian toxicity by inhibiting ferroptosis.铁抑素-1 通过抑制铁死亡来改善顺式-二氯二氨合铂（II）诱导的卵巢毒性。
Mol Med. 2024 Sep 13;30(1):150. doi: 10.1186/s10020-024-00923-7.
5
Gonadotropin Releasing Hormone agonist (GnRHa) during chemotherapy and post-cancer childbirths - a Nationwide population-based cohort study of 24,922 women diagnosed with cancer in Sweden.化疗期间及癌症后分娩时使用促性腺激素释放激素激动剂（GnRHa）——一项基于瑞典24922名癌症确诊女性的全国性队列研究。
EClinicalMedicine. 2023 Dec 7;67:102335. doi: 10.1016/j.eclinm.2023.102335. eCollection 2024 Jan.
6
ProFertil study protocol for the investigation of gonadotropin-releasing hormone agonists (GnRHa) during chemotherapy aiming at fertility protection of young women and teenagers with cancer in Sweden-a phase III randomised double-blinded placebo-controlled study.普罗菲特研究方案：旨在保护瑞典年轻女性和青少年癌症患者生育能力的化疗中促性腺激素释放激素激动剂（GnRHa）研究——一项 III 期随机双盲安慰剂对照研究
BMJ Open. 2023 Dec 9;13(12):e078023. doi: 10.1136/bmjopen-2023-078023.
7
Fertility preservation and monitoring in adult patients diagnosed with lymphoma: consensus-based practical recommendations by the Fondazione Italiana Linfomi & Società Italiana della Riproduzione Umana.成年淋巴瘤患者的生育力保存与监测：意大利淋巴瘤基金会和意大利人类生殖协会基于共识的实用建议
Front Oncol. 2023 Sep 12;13:1252433. doi: 10.3389/fonc.2023.1252433. eCollection 2023.
8
The Late Effects of Cancer Treatment on Female Fertility and the Current Status of Fertility Preservation-A Narrative Review.癌症治疗对女性生育力的晚期影响及生育力保存现状——一项叙述性综述
Life (Basel). 2023 May 17;13(5):1195. doi: 10.3390/life13051195.
9
Effects of ABVD chemotherapy on ovarian function: epidemiology, hormonal dosages and ultrasound morphologic analyses in 270 patients with Hodgkin's disease.ABVD化疗对卵巢功能的影响：270例霍奇金病患者的流行病学、激素剂量及超声形态学分析
Front Oncol. 2023 Apr 21;13:1059393. doi: 10.3389/fonc.2023.1059393. eCollection 2023.
10
Long-Term Effects of Breast Cancer Therapy and Care: Calm after the Storm?乳腺癌治疗与护理的长期影响：风暴过后归于平静？
J Clin Med. 2022 Dec 6;11(23):7239. doi: 10.3390/jcm11237239.